MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 11 analysts with an average price target of $5.19. This is a potential upside of $3.12 (150.72%) from yesterday's end of day stock price of $2.07.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 60 price targets and 76 ratings on display. The stock rating distribution of MRVI is 52.63% BUY, 44.74% HOLD and 2.63% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.57% with an average time for these price targets to be met of 77.55 days.

Highest price target for MRVI is $8, Lowest price target is $3, average price target is $8.69.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 25-Mar-2025. First documented stock forecast 15-Dec-2020.

Currently out of the existing stock ratings of MRVI, 20 are a BUY (52.63%), 17 are a HOLD (44.74%), 1 are a SELL (2.63%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$2.95 (143.90%)

$10

1 months 8 days ago
(25-Mar-2025)

3/13 (23.08%)

$2.7 (117.39%)

133

Buy

$8

$5.95 (290.24%)

$9

2 months ago
(03-Mar-2025)

2/4 (50%)

$4.98 (164.90%)

112

Buy

$3

$0.95 (46.34%)

$9

2 months 7 days ago
(26-Feb-2025)

4/5 (80%)

$-0.14 (-4.46%)

29

Sell

$4.25

$2.2 (107.32%)

$7

4 months 28 days ago
(05-Dec-2024)

11/12 (91.67%)

$-0.84 (-16.50%)

63

Buy

$10

$7.95 (387.80%)

$11

1 years 2 months 10 days ago
(23-Feb-2024)

4/7 (57.14%)

$1.64 (19.62%)

115

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 77.55 days on average for the stock forecasts to be realized with a an average price target met ratio 54.57

Which analyst has the current highest performing score on MRVI (Maravai Lifesciences Holdings ) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Tejas Savant works at MORGAN STANLEY and has 12 price targets and 2 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Erin Wright with highest potential upside - $39.7

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

Paul Knight with lowest potential downside - -$0

Maravai Lifesciences Holdings  in the News

Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 – MRVI

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. (“Maravai LifeSciences” or the “Company”) (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between...

Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) — Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target by at least one firm. The company is also facing a securities class action lawsuit alleging improper accounting. Hagens Berman is investigating the...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?